• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Unraveling the Pathophysiology of NASH through Changes in LipoQuality

Research Project

Project/Area Number 21H02892
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Review Section Basic Section 53010:Gastroenterology-related
Research InstitutionMie University

Principal Investigator

Nakagawa Hayato  三重大学, 医学系研究科, 教授 (00555609)

Co-Investigator(Kenkyū-buntansha) 工藤 洋太郎  東京大学, 医学部附属病院, 助教 (90608358)
Project Period (FY) 2021-04-01 – 2024-03-31
Project Status Completed (Fiscal Year 2023)
Budget Amount *help
¥17,420,000 (Direct Cost: ¥13,400,000、Indirect Cost: ¥4,020,000)
Fiscal Year 2023: ¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2022: ¥5,850,000 (Direct Cost: ¥4,500,000、Indirect Cost: ¥1,350,000)
Fiscal Year 2021: ¥6,500,000 (Direct Cost: ¥5,000,000、Indirect Cost: ¥1,500,000)
Keywords非アルコール性脂肪性肝疾患 / リン脂質代謝 / 脂質生合成経路 / 非アルコール性脂肪肝炎 / リン脂質代謝異常 / リン脂質 / 肝細胞癌
Outline of Research at the Start

NASHでは、肝線維化が進行すると肝組織中の脂肪沈着がむしろ減少・消失し、いわゆるburned-out NASHと呼ばれる状態となり、肝硬変・肝発癌の高リスクであることが知られている。これまでに遺伝子改変によってburned-out NASHを模倣する新規マウスモデルを樹立し、その機序として脂質生合成低下に伴う脂質の質的変化、特にリン脂質代謝の恒常性破綻が鍵を握っていることを見出した。そこで本提案では、オリジナルマウスモデルを基軸とし、豊富な臨床検体を組み合わせることで、NASHにおけるリン脂質の役割を多方面から解き明かすとともに、新規治療法やバイオマーカーを探索する。

Outline of Final Research Achievements

Enhanced de novo lipogenesis mediated by SREBP is thought to be involved in nonalcoholic steatohepatitis (NASH) pathogenesis. In this study, we assessed the impact of SREBP inhibition on NASH and liver cancer development in murine models. Unexpectedly, SREBP inhibition via deletion of SCAP in the liver exacerbated liver injury, fibrosis, and carcinogenesis, despite markedly reduced hepatic steatosis. SCAP-SREBP pathway inhibition altered the fatty acid (FA) composition of phosphatidylcholines due to both impaired FA synthesis and disorganized FA incorporation into phosphatidylcholine via LPCAT3 downregulation, which led to endoplasmic reticulum stress and hepatocyte injury. Thus, excessively strong and broad lipogenesis inhibition was counterproductive for NASH therapy, which will have important clinical implications in NASH treatment.

Academic Significance and Societal Importance of the Research Achievements

本研究結果から、進行したburned-out NASH で生じているSREBP を介した脂質生合成機能低下は、リン脂質組成の変化を介して病態進行を促進している可能性があり、リン脂質の補充や脂肪酸組み込み異常の是正が、進行NASH の治療法の一つとなる可能性が示唆された。また現在NASH に対して脂質生合成酵素を標的とした薬剤の開発が盛んに行われているが、過剰かつ広範な脂質生合成阻害はかえって病態を悪化させる可能性もあることがわかり、このことは今後の薬剤開発において重要な示唆を与えると思われる。

Report

(4 results)
  • 2023 Annual Research Report   Final Research Report ( PDF )
  • 2022 Annual Research Report
  • 2021 Annual Research Report
  • Research Products

    (19 results)

All 2024 2023 2022 2021

All Journal Article (8 results) (of which Peer Reviewed: 6 results,  Open Access: 4 results) Presentation (10 results) (of which Int'l Joint Research: 3 results,  Invited: 7 results) Book (1 results)

  • [Journal Article] The translation of oncogenic mRNAs regulated by pseudouridylation: A new player in HCC2024

    • Author(s)
      Nakagawa Hayato、Lin Aifu
    • Journal Title

      Hepatology

      Volume: in press Issue: 5 Pages: 1003-1005

    • DOI

      10.1097/hep.0000000000000761

    • Related Report
      2023 Annual Research Report
  • [Journal Article] Emerging role of spatial transcriptomics in liver research2024

    • Author(s)
      Fujiwara Naoto、Kimura Genki、Nakagawa Hayato
    • Journal Title

      Seminars in Liver Disease

      Volume: in press Issue: 02 Pages: 115-132

    • DOI

      10.1055/a-2299-7880

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Effectiveness of 1-year pemafibrate treatment on steatotic liver disease: the influence of alcohol consumption2024

    • Author(s)
      Iwasa Motoh、Sugimoto Ryosuke、Eguchi Akiko、Tamai Yasuyuki、Shigefuku Ryuta、Fujiwara Naoto、Tanaka Hideaki、Kobayashi Yoshinao、Ikoma Jiro、Kaito Masahiko、Nakagawa Hayato
    • Journal Title

      European Journal of Gastroenterology & Hepatology

      Volume: in press Issue: 6 Pages: 793-801

    • DOI

      10.1097/meg.0000000000002766

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Combination Therapy of Immune Checkpoint Inhibitors with Locoregional Therapy for Hepatocellular Carcinoma2023

    • Author(s)
      Tamai Yasuyuki、Fujiwara Naoto、Tanaka Takamitsu、Mizuno Shugo、Nakagawa Hayato
    • Journal Title

      Cancers

      Volume: 15 Issue: 20 Pages: 5072-5072

    • DOI

      10.3390/cancers15205072

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Lenvatinib recruits cytotoxic GZMK+CD8 T cells in hepatocellular carcinoma2023

    • Author(s)
      Yamada Tomoharu、Fujiwara Naoto、Kubota Naoto、Matsushita Yuki、Nakatsuka Takuma、Kurosaki Shigeyuki、Minami Tatsuya、Tateishi Ryosuke、Ichida Akihiko、Arita Junichi、Hasegawa Kiyoshi、Koike Kazuhiko、Fujishiro Mitsuhiro、Nakagawa Hayato
    • Journal Title

      Hepatology Communications

      Volume: 7 Issue: 8

    • DOI

      10.1097/hc9.0000000000000209

    • Related Report
      2023 Annual Research Report
  • [Journal Article] Inhibiting SCAP/SREBP exacerbates liver injury and carcinogenesis in murine nonalcoholic steatohepatitis2022

    • Author(s)
      Kawamura Satoshi、Matsushita Y、Kurosaki S、Tange M、Fujiwara N、Hayata Y、Hayakawa Y、Suzuki N、Hata M、Tsuboi M、Kishikawa T、Kinoshita H、Nakatsuka T、Sato M、Kudo Y、Hoshida Y、Umemura A、Eguchi A、Ikenoue T、Hirata Y、Uesugi M、Tateishi R、Tateishi Keisuke、Fujishiro Mitsuhiro、Koike K、Nakagawa H
    • Journal Title

      Journal of Clinical Investigation

      Volume: 132 Issue: 11

    • DOI

      10.1172/jci151895

    • Related Report
      2022 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Association of lithocholic acid with skeletal muscle hypertrophy through TGR5-IGF-1 and skeletal muscle mass in cultured mouse myotubes, chronic liver disease rats and humans2022

    • Author(s)
      Tamai Yasuyuki、Eguchi Akiko、Shigefuku Ryuta、Kitamura Hiroshi、Tempaku Mina、Sugimoto Ryosuke、Kobayashi Yoshinao、Iwasa Motoh、Takei Yoshiyuki、Nakagawa Hayato
    • Journal Title

      eLife

      Volume: 11

    • DOI

      10.7554/elife.80638

    • Related Report
      2022 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] A new detection system for serum fragmented cytokeratin 18 as a biomarker reflecting histologic activities of human nonalcoholic steatohepatitis.2022

    • Author(s)
      Eguchi A, Iwasa M, Yamada M, Tamai Y, Shigefuku R, Hasegawa H, Hirokawa Y, Hayashi A, Okuno K, Matsushita Y, Nakatsuka T, Enooku K, Sakaguchi K, Kobayashi Y, Yamaguchi T, Watanabe M, Takei Y, Nakagawa H.
    • Journal Title

      Hepatol Commun.

      Volume: 6 Issue: 8 Pages: 1987-1999

    • DOI

      10.1002/hep4.1971

    • Related Report
      2022 Annual Research Report
    • Peer Reviewed / Open Access
  • [Presentation] 肝細胞癌における微小環境解析の最新知見2023

    • Author(s)
      中川勇人
    • Organizer
      第82回癌学会総会
    • Related Report
      2023 Annual Research Report
    • Invited
  • [Presentation] 個別化医療を見据えたNAFLD肝生検組織の網羅的transcriptome解析2023

    • Author(s)
      中川勇人
    • Organizer
      第59回肝臓学会総会
    • Related Report
      2023 Annual Research Report
    • Invited
  • [Presentation] Genomic and molecular profiling-based personalized medicine for liver cancer.2022

    • Author(s)
      Nakagawa H
    • Organizer
      APASL Oncology
    • Related Report
      2022 Annual Research Report
    • Int'l Joint Research / Invited
  • [Presentation] Lipid Metabolism in NASH and NASH-related hepatocellular carcinoma.2022

    • Author(s)
      中川勇人
    • Organizer
      第81回癌学会総会
    • Related Report
      2022 Annual Research Report
    • Invited
  • [Presentation] Liver Cancer Research - Host Genome, Immunity and Pathology - Summary & Prospects2022

    • Author(s)
      中川勇人
    • Organizer
      第58回肝臓学会総会
    • Related Report
      2022 Annual Research Report
    • Invited
  • [Presentation] Inhibition of SCAP/SREBP-mediated lipogenesis exacerbates liver injury and carcinogenesis in murine NASH via phospholipid metabolism disturbance.2021

    • Author(s)
      Kawamura S, Nakagawa H, Koike K.
    • Organizer
      American Association for the Study of Liver Diseases (AASLD)
    • Related Report
      2021 Annual Research Report
    • Int'l Joint Research
  • [Presentation] Unexpected exacerbation of liver injury and carcinogenesis by inhibiting SCAP/SREBP in murine NASH.2021

    • Author(s)
      中川勇人
    • Organizer
      第80回癌学会総会
    • Related Report
      2021 Annual Research Report
    • Invited
  • [Presentation] Lipogenic pathway in NAFLD and NAFLD-related HCC: Friend or Foe?2021

    • Author(s)
      Nakagawa H
    • Organizer
      第57回肝臓学会総会JSH-AASLD Joint Session.
    • Related Report
      2021 Annual Research Report
    • Int'l Joint Research / Invited
  • [Presentation] Wnt/βカテニン経路活性化ニッチを標的とした肝発癌予防の可能性.2021

    • Author(s)
      黒崎滋之、中川勇人、小池和彦.
    • Organizer
      第57回肝臓学会総会
    • Related Report
      2021 Annual Research Report
  • [Presentation] Digital Spatial Profiling技術を用いたレンバチニブ投与後の腫瘍内免疫微小環境変化の検討.2021

    • Author(s)
      山田友春、中川勇人、小池和彦
    • Organizer
      第57回肝臓学会総会
    • Related Report
      2021 Annual Research Report
  • [Book] NASHの治療―薬物療法の現状と将来展望―2021

    • Author(s)
      中川勇人
    • Total Pages
      11
    • Publisher
      日本消化器病学会雑誌
    • Related Report
      2021 Annual Research Report

URL: 

Published: 2021-04-28   Modified: 2025-01-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi